Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma

Lynn G Feun,¹ Medhi Wangpaichitr,² Ying-Ying Li,¹ Deukwoo Kwon,³ Stephen P Richman,¹ Peter J Hosein,¹ Niramol Savaraj¹,² ¹Department of Medicine, Medical Oncology, Sylvester Comprehensive Cancer Center, University of Mi...

Full description

Bibliographic Details
Published in:Journal of Hepatocellular Carcinoma
Main Authors: Feun LG, Wangpaichitr M, Li YY, Kwon D, Richman SP, Hosein PJ, Savaraj N
Format: Article
Language:English
Published: Dove Medical Press 2018-01-01
Subjects:
pasireotide
hepatocellular carcinoma
Online Access:https://www.dovepress.com/phase-ii-trial-of-som230-pasireotide-lar-in-patients-with-unresectable-peer-reviewed-article-JHC

Internet

https://www.dovepress.com/phase-ii-trial-of-som230-pasireotide-lar-in-patients-with-unresectable-peer-reviewed-article-JHC

Similar Items